-
DailyClout Makes Legislation Easy to Understand, Share and Act Upon
Join the Community
Search BillCam
-
LET'S SAVEDEMOCRACYTOGETHER
September 8, 2025
DailyClout
Tara Reade Alleges Jill and Hunter Biden Acted as “De Facto Presidents”
Tara Reade, the former Senate aide who accused Joe Biden of sexual assault in the 1990s, has filed a $100 million tort claim against the Department of Justice and FBI, alleging retaliation for going public with her allegations. In a recent interview, Reade said she amended her lawsuit to also …
September 8, 2025
DailyClout
Thune Accuses Democrats of Obstructing Trump Nominees
Senate Majority Whip John Thune (R-SD) is ramping up pressure on Democrats over what he calls unprecedented obstruction of President Donald Trump’s nominees. According to Thune, Democrats have used procedural tactics to stall appointments across federal agencies, leaving critical posts unfilled and forcing Republicans to weigh more drastic measures. “Democrats …
September 8, 2025
DailyClout
RFK Jr.: Public Health Agencies in Decline
During a recent exchange, Robert F. Kennedy Jr. was asked what he considered the last great success of America’s public health agencies. His answer was stark: “I don’t think there have been successes. I think we’ve seen a 30 or 40 year decline in the agency because it’s been infiltrated …
September 8, 2025
DailyClout
RSV Vaccine Safety Signals Raise Alarming Questions
A new peer-reviewed pharmacovigilance study published in Human Vaccines & Immunotherapeutics analyzed nearly 18,000 adverse event reports tied to the three FDA-approved RSV vaccines — Pfizer’s Abrysvo, GSK’s Arexvy, and Moderna’s mRESVIA. The results raise urgent concerns about vaccine safety, especially for seniors and pregnant women. A Pharmacovigilance Study with …
September 6, 2025
DailyClout
FDA Publishes New Drug Rejection Letters
The FDA has released another batch of drug rejection letters, following up on the 200 complete response letters (CRLs) made public earlier this summer. The newly disclosed documents, spanning 2024 and 2025, shed light on the agency’s reasoning behind several high-profile rejections, from psychedelic therapies to ultra-rare disease treatments. The …

Search BillCam










